ArticleJournal of parasitology research2026
Seroprevalence of Fascioliasis in Patients Referred to the Reference Laboratory in Urmia, Northwest Iran.
Article in Journal of parasitology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Seroprevalence of Fascioliasis in Patients Referred to the Reference Laboratory in Urmia, Northwest Iran.Journal of parasitology research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Iran is one of the most important foci of human fascioliasis. West Azerbaijan Province is known for its traditional rural livestock husbandry, supported by many rivers. This environment could facilitate the transmission of fascioliasis between animals and humans. Thus, the present study investigated the seroprevalence of fascioliasis in patients referred to the Reference Laboratory in Urmia, Northwest Iran. Materials and Methods: In this cross-sectional study, 919 sera were collected from patients referred to the Reference Laboratory of Urmia University of Medical Sciences from January to June 2023. The samples were examined by Enzyme-Linked Immunosorbent Assay(ELISA) to detect IgG antibodies against Results: Of 919 sera tested, 532 (57.9%) and 387 (42.1%) were women and men, respectively. Among 919 subjects, three (0.326%) were seropositive for fascioliasis. Of the three positive cases, two were women aged 31 and 79 years, and one was a 60-year-old man; all were rural residents. All three positive cases had livestock around them in the village. Because of the small number of positive cases, further statistical analysis was not performed. Conclusion: The present findings suggest the presence of human fascioliasis in the Urmia District, West Azerbaijan Province, Northwest Iran, especially in rural areas, with a low prevalence. Therefore, the health care systems require educating the residents of the villages about fascioliasis, the route of its transmission, and strategies required for prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.